Clinical Trial Update: A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of NKTR-181 on brain activity using fMRI in healthy recreational opioid users; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Chronic Pain

Drugs mentioned

• NKTR-181

Snippet

Sponsor: Nektar Therapeutics | Conditions: Moderate to Severe Chronic Pain | Phase 1 | Status: TERMINATED | Results posted: 2021-05-27